
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
Saphetor is exhibiting at this year's European Society of Human Genetics conference in Glasgow, Scotland.
Our Head of Regulatory Affairs and Quality Assurance, Amélie Martinez, was featured in Inside Precision Medicine in an interview covering the upcoming impact and practical considerations labs are facing regarding IVDR.
Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...
Press Releases Partnerships News
Conferences Partnerships Events News
RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...
Press Releases Partnerships News
Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...
Press Releases Partnerships News
Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...
Saphetor was featured in Nature Portfolio's Biopharma Dealmakers this week. The article explains how and why Saphetor developed VarSome. You can read the full article here.
VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.
Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...
VarSome Suite is brought to you by Saphetor SA.
© 2023 Saphetor SA – All Rights Reserved.